Excellio

We are looking forward to the summit!

We  are happy to announce that Excellio has made it to the finals of the Converge Challenge! 🎉 The talent and innovation we’ve encountered throughout the Converge program has been inspiring, and we are proud that Excellio is standing among such impressive finalists. 🚀 Best of luck to all the other finalists! Let’s continue pushing the boundaries of science and innovation. Looking forward to catching up with everyone at the awards night. 🤝 Stay tuned for more updates as we shape the future of precision medicine! 🔬✨

We  are happy to announce that Excellio has made it to the finals of the Converge Challenge! 🎉 The talent and innovation we’ve encountered throughout the Converge program has been inspiring, and we are proud that Excellio is standing among such impressive finalists. 🚀 Best of luck to all the other finalists! Let’s continue pushing the boundaries of science and innovation. Looking forward to catching up with everyone at the awards night. 🤝 Stay tuned for more updates as we shape the future of precision medicine! 🔬✨

Six start-ups move to Phase II of CRUK’s Tech Accelerator https://lnkd.in/eRXm5zXK #CancerResearch #Cancer #Oncology Siftr Bio SynPixels Senesys.Bio Excellio

We’re thrilled to be moving on to Phase II of Cancer Tech Accelerator ! Thank you to the panel and everyone involved for this incredible opportunity. Congratulations to all the other teams as well—we’re excited to be part of such an inspiring community! #innovation #cancertech #accelerator

Did you know that blood-brain-barrier (BBB) limits penetration of more than 98% of drugs? This poses a significant challenge to treatment for some of the diseases that affect the brain including Alzheimer’s disease 🧠   💡 A novel drug delivery method might just be an answer Our founders, Kasia Maj and Kamila Małysz, discuss how astrocyte-derived exosomes can offer a targeted and more efficient approach to drug delivery to the brain, overcoming the BBB limitations. 🧐 Read the full article here: https://lnkd.in/e3gp4ZMq #Exosomes #AlzheimersDisease #BloodBrainBarrier #DrugDelivery #Neurodegeneration #Astrocytes #Innovation

🧬𝐀𝐩𝐭𝐚𝐦𝐞𝐫𝐬, known for their high specificity and affinity, are revolutionizing the field of 𝐞𝐱𝐭𝐫𝐚𝐜𝐞𝐥𝐥𝐮𝐥𝐚𝐫 𝐯𝐞𝐬𝐢𝐜𝐥𝐞𝐬 (EVs). 🧪By targeting specific cells and tissues, aptamer-conjugated EVs can deliver drugs, RNA, or proteins with unprecedented precision, reducing off-target effects and improving treatment efficacy. 📖Here is the latest publication in Nanoscale, where the authors explore the innovative intersection of aptamer technology and extracellular vesicles, shedding light on their potential in diagnostics and targeted therapies. Read the full article here: https://lnkd.in/eRPexeab #Biotech #ExtracellularVesicles #Aptamers #Therapeutics #Innovation #Exosomes #DrugDelivery Follow us for more insights and updates in the field of exosomes.

🎉 Exciting Milestone Alert! 🎉 We are thrilled to announce that we have reached 500 followers on LinkedIn! 🥳 Thank you to each and every one of you for your incredible support and belief in our mission. As a startup founded by two passionate women,Kasia Maj and Kamila Małysz, we are committed to revolutionizing the field of exosomes and drug delivery 🧫 Your encouragement and engagement mean the world to us. This journey is just beginning, and we are grateful to have such a vibrant and supportive community by our side. Stay tuned for more updates, breakthroughs, and opportunities to collaborate. Here's to many more milestones together! 🚀🎉 #exosomes #drugdelivery #innovation #womeninscience #startup #biotech

🚀 It’s been an incredibly exciting and productive week for our team at Excellio! Last week, our CSO @Kamila Malysz participated in the @Converge business training program. The intense three-day workshops culminated in networking event at the National Gallery, where Kamila and other semi-finalists delivered powerful 1-minute pitches. We’re grateful to Converge for providing us with invaluable training and access to top mentors and for fostering such a supportive community! Meanwhile, our CEO @Kasia Maj headed to London, to present our company at the Pitch Day Event by the Cancer Tech Accelerator. This was great opportunity to showcase our innovative solutions in the fight against cancer to the industry experts. On Thursday, Kamila was honoured with the Emerging Female Entrepreneur Award at the Inspire Launch Grow organized by Edinburgh Innovations. It was great to see the event and award featured in The Times. Stay tuned for more updates as we continue to drive forward with our mission to revolutionize medicine. #CancerTechAccelerator #Converge #Innovation #Entrepreneurship

🌟 Celebrating Excellence at the Inspire Launch Grow Awards! 🌟 We are thrilled that our very own Kamila Małysz, CSO of Excellio, has been honored as the Emerging Female Entrepreneur at The University of Edinburgh's prestigious Inspire Launch Grow Awards! Kamila's dedication and innovative spirit truly shine, and we couldn't be prouder of her remarkable achievement. This award is a testament to her hard work and the impact she is making in the field. Congratulations to all the winners and finalists! Here's to many more successes! 🎉 Well done, Kamila! 🎉